Sort
130,381 grants matching “hiv”
High-throughput mapping of antigen specificity to B-cell-receptor sequence for characterizing antibody responses in HIV-vaccinated and infected individuals
$823,824Ivelin Georgiev · Vanderbilt University Medical Center · R01 · FY2023 · AI
Development of an mRNA-Based Therapeutic HIV/AIDS Vaccine
$823,817Afamefuna Okoye · Oregon Health & Science University · R01 · FY2022 · AI
Gag Trafficking, Assembly, and Release
$823,711Eric Freed · Division Of Basic Sciences - Nci · ZIA · FY2022 · CA
Envelope Glycoprotein Incorporation and Function
$823,711Eric Freed · Division Of Basic Sciences - Nci · ZIA · FY2022 · CA
Immune checkpoints in the CNS and HIV-associated neurocognitive disorder
$823,691Qigui Yu · Indiana University Indianapolis · R56 · FY2023 · NS
THE GENERALIZABILITY OF HIV RISK REDUCTION STRATEGIES
$823,676University Of Pennsylvania · R01 · FY2002 · HD
Motor Dysfunction in cART-era HIV: Neural Circuitry and Pathogenesis
$823,630Susan Morgello · Icahn School Of Medicine At Mount Sinai · R01 · FY2021 · NS
Motor Dysfunction in cART-era HIV: Neural Circuitry and Pathogenesis
$823,630Susan Morgello · Icahn School Of Medicine At Mount Sinai · R01 · FY2020 · NS
Motor Dysfunction in cART-era HIV: Neural Circuitry and Pathogenesis
$823,630Susan Morgello · Icahn School Of Medicine At Mount Sinai · R01 · FY2022 · NS
Pharmacogenomics and Systems Pharmacology Approaches to Toxicity, Tolerability, and Comorbidities Associated with Modern Antiretroviral Therapies
$823,609Inga Peter · Icahn School Of Medicine At Mount Sinai · R01 · FY2022 · HG
T-cell depletion and maintenance of the HIV-1 latent reservoir in distinct tissue compartments
$823,537Aaron A Tobian · Johns Hopkins University · R01 · FY2022 · DK
ACTIVITY #1 - PROTEOMICS DISCOVERY FACILITY
$823,523Loyda M Melendez · University Of Puerto Rico Med Sciences · G12 · FY2007 · RR
The Impact of Aging and HIV Infection on Immunologic and Transcriptomic Signatures of Influenza Vaccine Response
$823,522Albert C Shaw · Yale University · R01 · FY2018 · AG
Genomics Core
$823,491Nalini Raghavachari · National Heart, Lung, And Blood Institute · ZIC · FY2010 · HL
Pharmacogenomics and Systems Pharmacology Approaches to Toxicity, Tolerability, and Comorbidities Associated with Modern Antiretroviral Therapies
$823,490Inga Peter · Icahn School Of Medicine At Mount Sinai · R01 · FY2023 · HG
Developmental Effects of Prenatal Cocaine Exposure
$823,488Michael Lewis · Univ Of Med/Dent Nj-R W Johnson Med Sch · R01 · FY2010 · DA
Biostatistics and Data Management Section
$823,438Seth M Steinberg · Clinical Sciences · Z01 · FY2007 · CA
Vaccination with invariant MHC-II-linked accessory antigens for protection from HIV infection
$823,420Ronald S. Veazey · Tulane University Of Louisiana · R01 · FY2022 · AI
Core C
$823,378Jinwoo Ahn · University Of Pittsburgh At Pittsburgh · P50 · FY2011 · GM
Health Research Core (HR)
$823,363Valerie Wojna · University Of Puerto Rico Med Sciences · P50 · FY2025 · GM
A systems biology approach to fingerprint HIV immune defense in Elite Controllers
$823,340Xu Yu · Massachusetts General Hospital · R01 · FY2017 · HL
PS12-1201 COMPREHENSIVE HIV PREVENTION PROJECT FOR HEALTH DEPTS
$823,331Aimee Shipman · Idaho State Dept Of Health And Welfare · U62 · FY2013 · PS
Exploratory Human Trials of Combination Rectal Microbicides
$823,265Ian Michael McGowan · Magee-Women'S Res Inst And Foundation · U19 · FY2010 · AI
Cardiovascular Risk Reduction in an Aging HIV-Infected Population: The Impact of HCV Co-Infection
$823,218Virginia Athena Triant · Massachusetts General Hospital · R01 · FY2020 · AG
Community-Based HIV VCT: South Africa
$823,200Thomas J. Coates · University Of California Los Angeles · U01 · FY2009 · MH